In prostate cancer, the protein kinase CK2 was shown to impede Hhex by phosphorylation-induced inhibition of Hhex’s DNA binding, allowing increased proliferation and migration of prostate cancer cell lines (127). This evidence concerns the gene HHEX and prostate carcinoma.